logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Woodcock, Ashley Arthur, Professor
    Born in April 1951
    Individual (3 offsprings)
    Officer
    icon of calendar 2021-02-24 ~ now
    OF - Director → CIF 0
  • 2
    Courtney, Thomas
    Born in April 1964
    Individual (1 offspring)
    Officer
    icon of calendar 2024-04-05 ~ now
    OF - Director → CIF 0
  • 3
    Mr Jonathan Paul Moulton
    Born in October 1950
    Individual (47 offsprings)
    Person with significant control
    icon of calendar 2021-03-16 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
  • 4
    Kitt, Michael
    Born in March 1950
    Individual (1 offspring)
    Officer
    icon of calendar 2021-03-31 ~ now
    OF - Director → CIF 0
  • 5
    Field, Adrian Ivery
    Born in June 1974
    Individual (15 offsprings)
    Officer
    icon of calendar 2021-03-16 ~ now
    OF - Director → CIF 0
  • 6
    Glyer, Paul Hartley
    Born in January 1957
    Individual (1 offspring)
    Officer
    icon of calendar 2021-03-16 ~ now
    OF - Director → CIF 0
Ceased 4
  • 1
    Rochat, Marc-henry Peppo Jules
    Finance Director born in September 1954
    Individual
    Officer
    icon of calendar 2021-03-16 ~ 2024-04-05
    OF - Director → CIF 0
  • 2
    Professor Ashley Arthur Woodcock
    Born in April 1951
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2021-02-24 ~ 2021-03-16
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 3
    Vitins, Peter
    Retired born in August 1945
    Individual
    Officer
    icon of calendar 2021-03-16 ~ 2024-04-05
    OF - Director → CIF 0
  • 4
    Poirot, Olivier Ernest Louis William, Dr
    Chief Scientific Officer born in February 1977
    Individual
    Officer
    icon of calendar 2025-03-12 ~ 2025-03-12
    OF - Director → CIF 0
parent relation
Company in focus

AXALBION THERAPEUTICS LIMITED

Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Average Number of Employees
72023-01-01 ~ 2023-12-31
72022-01-01 ~ 2022-12-31
Other Investments Other Than Loans
Non-current
4,464,399 GBP2023-12-31
4,464,399 GBP2022-12-31
Fixed Assets - Investments
4,464,399 GBP2023-12-31
4,464,399 GBP2022-12-31
Debtors
98,403 GBP2023-12-31
988,989 GBP2022-12-31
Cash at bank and in hand
128,046 GBP2023-12-31
46,883 GBP2022-12-31
Current Assets
226,449 GBP2023-12-31
1,035,872 GBP2022-12-31
Creditors
Amounts falling due within one year
69,251 GBP2023-12-31
353,882 GBP2022-12-31
Net Current Assets/Liabilities
157,198 GBP2023-12-31
681,990 GBP2022-12-31
Total Assets Less Current Liabilities
4,621,597 GBP2023-12-31
5,146,389 GBP2022-12-31
Creditors
Amounts falling due after one year
1,063,027 GBP2023-12-31
521,591 GBP2022-12-31
Net Assets/Liabilities
3,558,570 GBP2023-12-31
4,624,798 GBP2022-12-31
Equity
Called up share capital
1,247,713 GBP2023-12-31
1,247,713 GBP2022-12-31
Share premium
2,823,209 GBP2023-12-31
2,823,209 GBP2022-12-31
Retained earnings (accumulated losses)
-5,138,766 GBP2023-12-31
-4,072,538 GBP2022-12-31
Equity
3,558,570 GBP2023-12-31
4,624,798 GBP2022-12-31
Amounts invested in assets
Non-current
4,464,399 GBP2023-12-31
4,464,399 GBP2022-12-31
Trade Debtors/Trade Receivables
4,024 GBP2022-12-31
Amounts owed by group undertakings and participating interests
40,426 GBP2023-12-31
Other Debtors
57,977 GBP2023-12-31
984,965 GBP2022-12-31
Trade Creditors/Trade Payables
Amounts falling due within one year
50,551 GBP2023-12-31
311,619 GBP2022-12-31
Other Creditors
Amounts falling due within one year
18,700 GBP2023-12-31
42,263 GBP2022-12-31
Amounts falling due after one year
1,063,027 GBP2023-12-31
521,591 GBP2022-12-31

  • AXALBION THERAPEUTICS LIMITED
    Info
    Registered number 13224059
    icon of address3rd Floor 1 Ashley Road, Altrincham, Cheshire WA14 2DT
    PRIVATE LIMITED COMPANY incorporated on 2021-02-24 (4 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.